Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-15 @ 4:13 PM
Study NCT ID:
NCT02666612
Status:
UNKNOWN
Last Update Posted:
2017-01-26
First Post:
2015-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009362', 'term': 'Neoplasm Metastasis'}], 'ancestors': [{'id': 'D009385', 'term': 'Neoplastic Processes'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D001800', 'term': 'Blood Specimen Collection'}], 'ancestors': [{'id': 'D013048', 'term': 'Specimen Handling'}, {'id': 'D019411', 'term': 'Clinical Laboratory Techniques'}, {'id': 'D019937', 'term': 'Diagnostic Techniques and Procedures'}, {'id': 'D003933', 'term': 'Diagnosis'}, {'id': 'D011677', 'term': 'Punctures'}, {'id': 'D013514', 'term': 'Surgical Procedures, Operative'}, {'id': 'D008919', 'term': 'Investigative Techniques'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'DIAGNOSTIC', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 2240}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2008-08', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-01', 'completionDateStruct': {'date': '2023-08', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2017-01-25', 'studyFirstSubmitDate': '2015-08-12', 'studyFirstSubmitQcDate': '2016-01-27', 'lastUpdatePostDateStruct': {'date': '2017-01-26', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2016-01-28', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2023-08', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Measurement and characterization of CEC and CEP and circulaing DNA rate using flow cytometry', 'timeFrame': 'up to 2 years', 'description': 'Measurement and characterization of initial CEC and CEP circulaing DNA and their evolution under treatment'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Patients'], 'conditions': ['Metastatic Cancer']}, 'descriptionModule': {'briefSummary': 'Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients with metastatic solid tumor\n* Age\\> 18 years\n* Signed consent\n\nExclusion Criteria:\n\n* Patients with diseases associated with vascular lesions known.\n* Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the Code of Public Health.\n* Mental pathology that can interfere with the proper conduct of the study.\n* Refusal of consent.'}, 'identificationModule': {'nctId': 'NCT02666612', 'acronym': 'Liquid Biopsy', 'briefTitle': 'Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer', 'organization': {'class': 'OTHER', 'fullName': 'Gustave Roussy, Cancer Campus, Grand Paris'}, 'officialTitle': 'Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer', 'orgStudyIdInfo': {'id': '2008-A00585-50'}, 'secondaryIdInfos': [{'id': '2008/1370', 'type': 'OTHER', 'domain': 'CSET number'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'OTHER', 'label': 'Patients with metastatic cancer', 'interventionNames': ['Procedure: Blood samples']}], 'interventions': [{'name': 'Blood samples', 'type': 'PROCEDURE', 'armGroupLabels': ['Patients with metastatic cancer']}]}, 'contactsLocationsModule': {'locations': [{'zip': '94805', 'city': 'Villejuif', 'state': 'Val de Marne', 'status': 'RECRUITING', 'country': 'France', 'contacts': [{'name': 'Jean Charles Soria, MD-PhD', 'role': 'CONTACT', 'email': 'soria@gustaveroussy.fr', 'phone': '0142114291', 'phoneExt': '+33'}], 'facility': 'Gustave Roussy Cancer Campus Grand Paris', 'geoPoint': {'lat': 48.7939, 'lon': 2.35992}}], 'centralContacts': [{'name': 'Jean Charles Soria, MD-PhD', 'role': 'CONTACT', 'email': 'soria@gustaveroussy.fr', 'phone': '0142114291', 'phoneExt': '+33'}], 'overallOfficials': [{'name': 'Jean Charles Soria, MD-PhD', 'role': 'STUDY_CHAIR', 'affiliation': 'Gustave Roussy Cancer Campus'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Gustave Roussy, Cancer Campus, Grand Paris', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}